DEVELOPMENT OF SP16 AS AN IMMUNOMODULATORY THERAPY FOR IMPROVED REGENERATION OF FUNCTIONAL SKELETAL MUSCLE IN THE TREATMENT OF VOLUMETRIC MUSCLE LOSS
$302,198FY2021Defense Health AgencyDOD
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.